Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Precision Genetics logo — Leveraging the power of genomics to advance precision medici...

Precision Genetics

Leveraging the power of genomics to advance precision medicine for better prescribing outcomes for patients

Founded 2017 United States Greenville, United States 29 employees Biotechnology, Pharmaceutical

General Information

Company Name Precision Genetics
Founded Year 2017
Location United States Greenville, United States +2
Employees 29
Industries Biotechnology, Pharmaceutical
Social

Get notified when Precision Genetics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Precision Genetics

Precision Genetics is a biotechnology and pharmaceutical startup with a mission to leverage the power of genomics for advancing precision medicine and improving prescribing outcomes for patients. The company provides comprehensive lab and genetics testing solutions, including COVID and pharmacogenomics, to enhance overall patient outcomes. By integrating evidence-based technology and population risk analysis, Precision Genetics offers a solution that allows healthcare providers to promptly deliver personalized treatment and prevention plans. This approach not only reduces interaction and efficacy risks but also ensures the appropriate use of medications for therapies. Utilizing genetic markers, molecular data, and clinical evidence, Precision Genetics empowers busy physicians and providers to immediately develop individualized treatment and prevention plans for their patients. Moreover, the company's interactive tools enable patients to address their individual risks and treatment pathways based on their unique genetics, demographics, lifestyle, and medical conditions. Founded in 2017, Precision Genetics aims to revolutionize precision medicine by providing actionable insights and personalized approaches to healthcare. As a potential investment opportunity, Precision Genetics operates in promising sectors such as biotechnology and pharmaceuticals. However, information regarding the last investment, investors, location, and funding amount is currently unavailable, making it essential to delve deeper into the company's financial status and growth prospects. Keep an eye on Precision Genetics for its potential to drive innovation and address critical healthcare challenges through genomics and personalized medicine.

Taxonomy: Precision Genetics, Genetic Testing, Pharmacogenomics, Biotech, HealthTech, Molecular Diagnostics, Precision Medicine, Medication Risk Mitigation, Anesthesiology, Primary Care, Personalized Medicine

No funding data available for Precision Genetics yet.

Get notified when Precision Genetics raises funding

FAQ About Precision Genetics

Leveraging the power of genomics to advance precision medicine for better prescribing outcomes for patients
Precision Genetics was founded in 2017.
Precision Genetics is headquartered in Greenville, United States.
Precision Genetics operates in the following industries: Biotechnology, Pharmaceutical.
Precision Genetics has approximately 29 employees.

We're actively collecting intelligence on Precision Genetics.

Track Precision Genetics to get notified

Don't just browse. Track.

Signal Tracker monitors Precision Genetics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes